Skip to main content
Hematology and Oncology
ALL Specialities
ALL Specialities
/
Hematology and Oncology
Blood & Cancer Podcast
CME
Diseases & Conditions
Nonmalignant Hematologic Disorders
Anemia
Bleeding Disorders
Thrombosis
Breast Cancer
CNS/Brain Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Renal Cell Carcinoma
Gynecologic Cancer
Head & Neck/Thyroid Cancers
Leukemia, Myelodysplasia, Transplantation
ALL
AML
Cellular Therapy
CLL
CML
Myelodysplastic Syndrome
Transplantation
Lung Cancer
Lymphoma & Plasma Cell Disorders
B Cell Lymphoma
Follicular Lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Non-Hodgkin Lymphoma
T Cell Lymphomas
Melanoma
Nonmelanoma Skin Cancer
Sarcoma and GIST
COVID-19 Updates
Conference Coverage
Latest News
AMA, 55 other groups urge health care vax mandate
Publish date:
July 27, 2021
A version of this article first appeared on
Medscape.com
.
Pages
« first
1
2
Recommended Reading
Delta becomes dominant coronavirus variant in U.S.
MDedge Hematology and Oncology
Extra COVID-19 vaccine could help immunocompromised people
MDedge Hematology and Oncology
Delta variant key to breakthrough infections in vaccinated Israelis
MDedge Hematology and Oncology
Are oncologists liable for pandemic-related treatment delays?
MDedge Hematology and Oncology
‘Long haul’ COVID recovery worse than cancer rehab for some: CDC
MDedge Hematology and Oncology
FDA to warn J&J that vaccine can increase Guillain-Barré risk: Media
MDedge Hematology and Oncology
Do patients with cancer need a third shot of COVID vaccine?
MDedge Hematology and Oncology
When patients demand vaccinated health care providers
MDedge Hematology and Oncology
Sickle cell disease, trait may up risk for poor COVID outcomes
MDedge Hematology and Oncology
Vaccine breakthrough cases rising with Delta: Here’s what that means
MDedge Hematology and Oncology
COVID-19 Updates
All Specialties
